John Marous
Director/Board Member at Heart Input Output, Inc.
Profile
John Marous currently works at Heart Input Output, Inc., as Director and Gid Bio Inc., as Director.
John Marous active positions
| Companies | Position | Start |
|---|---|---|
Heart Input Output, Inc.
 Heart Input Output, Inc. Packaged SoftwareTechnology Services Heart Input Output, Inc. provides cloud-based tool using data from electrocardiograms to develop deep learning algorithms focused on individualized predictions through identifying arterial stenosis. It specializes in beat detection, rhythm analysis, disease detection, and Major Adverse Cardiac Events (MACE) risk analysis. The company is headquartered in Pittsburgh, PA. | Director/Board Member | - |
Gid Bio Inc.
 Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Heart Input Output, Inc.
Heart Input Output, Inc. Packaged SoftwareTechnology Services Heart Input Output, Inc. provides cloud-based tool using data from electrocardiograms to develop deep learning algorithms focused on individualized predictions through identifying arterial stenosis. It specializes in beat detection, rhythm analysis, disease detection, and Major Adverse Cardiac Events (MACE) risk analysis. The company is headquartered in Pittsburgh, PA. | Technology Services |
Gid Bio Inc.
Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Health Services |
- Stock Market
- Insiders
- John Marous
